InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,498.78
(
0.29%
)
US TECH 100
19,321.15
(
0.29%
)
Dow Jones
39,258.64
(
0.24%
)
Brent Oil
84.70
(
-0.84%
)
Bitcoin
60,867.50
(
-1.21%
)
Post# of 701832
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Umibe5690

Send PM Follow Ignore
Followers 44
Posts 864
Boards Moderated 0
Alias Born 03/08/2014

Umibe5690

Re: scotty3371 post# 179095

Friday, 06/22/2018 12:07:59 AM

Friday, June 22, 2018 12:07:59 AM

Post# of 701832
Of course he has. His practice is certainly not limited to patients associated with the trial. Dr. Ashkans is both a respected researcher and clinician as is Dr. Liau. His expertise is made available to patients in need both in and outside of the trial.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!